
Journal of Medicinal Chemistry p. 985 - 990 (1980)
Update date:2022-08-10
Topics:
Reifenrath, William G.
Roche, Edward B.
Al-Turk, Walid A.
Johnson, Howard L.
N-Ethyl-, N-(2-fluoroethyl)-, N-(2,2-difluoroethyl)-, and N-(2,2,2-trifluoroethyl)-substituted normeperidine (1b-e) and normetazocine (2b-e) derivatives were prepared.The analgesic activities of the compounds were determined in mice.Opiate receptor binding studies, in the presence and absence of sodium ion, were carried out.The antagonist activities of normetazocine derivatives were studied in monkeys.These were further examined in the isolated guinea pig ileum for agonist activity.These pKa values were measured in vivo agonist activity was lost with the weakly bas ic derivatives.For the normetazocine derivatives, opiate receptor binding data were consistent with guinea pig ileum agonist potency and mouse vas deferens antagonist potency but not in vivo data.Opiate receptor binding was reduced for the less basic normetazocine derivatives.In the normeperidine series, there was no apparent direct relationship between pKa and opiate receptor binding.However, a relationship involving the hydrophobic character of the N-substituent is discussed.The N-(2-fluoroethyl) derivatives in both series were found to cause convulsions in rats at doses of 40-45 mg/kg ip.Elevated serum citrate levels were found in these rats, implicating in vivo oxidative deamination of the N-(fluoroalkyl) substituent to fluoroacetate.
View More
Taizhou Elitechemie MediPharma Technology Co.,Ltd.
Contact:+86-523-86810021
Address:Building G14,NO.1 Avenue,China Medical City, Taizhou, Jiangsu,China
Improve Medical Technology(Nanxiong) Co., Ltd
Contact:86-751-3836997
Address:No.33, Pingan First Road, Fine Chemical Industry Base, Nanxiong City, Shaoguan, Guangdong, China
Anhui Biochem United Pharmaceutical Co., Ltd.
Contact:0086 551 5167062 / 5228268
Address:No. 30 Hongfeng Road, Hi-Tech Development Zone, Hefei (230088), China
Shao Xing Empire Import&Export CO.,ltd
Contact:86-575-82127757
Address:11#, Weiwu Road, Shangyu Industrial Park, Hangzhou Bay, Hangzhou, Zhejiang Province, China
Shanghai Dano Pharmaceutical Co.,Ld.(expird)
Contact:+86-592-6266840
Address:Building 1 Room 512, 720 Cailun Rd, Zhangjiang High-Tech Park, Shanghai 201203, China
Doi:10.1016/j.bmcl.2020.127746
(2021)Doi:10.1016/j.tetlet.2006.01.114
(2006)Doi:10.1080/00397910600632096
(2006)Doi:10.1016/j.jallcom.2019.04.337
(2019)Doi:10.1021/ja9613668
(1997)Doi:10.1016/j.ica.2020.119586
(2020)